Norway Savings Bank’s Pfizer PFE Stock Holding History

Norway Savings Bank’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$258K	Sell	10,701 -476	-4%	-$12.5K	0.11%	98
2026 Q1	$314K	Buy	11,177 +51	+0.5%	+$1.36K	0.15%	95
2025 Q4	$277K	Sell	11,126 -1,365	-11%	-$34.4K	0.13%	96
2025 Q3	$318K	Sell	12,491 -1,015	-8%	-$25.1K	0.15%	93
2025 Q2	$327K	Sell	13,506 -958	-7%	-$22.3K	0.17%	91
2025 Q1	$367K	Sell	14,464 -1,584	-10%	-$41.4K	0.21%	87
2024 Q4	$426K	Buy	16,048 +124	+0.8%	+$3.36K	0.24%	84
2024 Q3	$461K	Sell	15,924 -2,765	-15%	-$80.7K	0.25%	83
2024 Q2	$523K	Buy	18,689 +425	+2%	+$11.7K	0.3%	78
2024 Q1	$507K	Sell	18,264 -2,815	-13%	-$78.1K	0.21%	105
2023 Q4	$607K	Sell	21,079 -3,133	-13%	-$94.7K	0.27%	98
2023 Q3	$803K	Sell	24,212 -947	-4%	-$33.5K	0.4%	87
2023 Q2	$923K	Sell	25,159 -1,997	-7%	-$77.7K	0.5%	70
2023 Q1	$1.11M	Sell	27,156 -995	-4%	-$43K	0.56%	64
2022 Q4	$1.44M	Sell	28,151 -56	-0.2%	-$2.69K	0.73%	47
2022 Q3	$1.24M	Sell	28,207 -1,890	-6%	-$91.8K	0.67%	52
2022 Q2	$1.58M	Sell	30,097 -805	-3%	-$41K	0.82%	41
2022 Q1	$1.6M	Sell	30,902 -155	-0.5%	-$8.04K	0.72%	46
2021 Q4	$1.83M	Buy	31,057 +335	+1%	+$16.6K	0.8%	43
2021 Q3	$1.32M	Buy	30,722 +2,044	+7%	+$90.5K	0.62%	52
2021 Q2	$1.12M	Sell	28,678 -508	-2%	-$19.8K	0.55%	62
2021 Q1	$1.06M	Buy	29,186 +50	+0.2%	+$1.77K	0.56%	60
2020 Q4	$1.07M	Sell	29,136 -166	-0.6%	-$6.09K	0.62%	55
2020 Q3	$1.02M	Buy	29,302 +2,624	+10%	+$92K	0.69%	49
2020 Q2	$828K	Buy	26,678 +2,567	+11%	+$87.2K	0.61%	51
2020 Q1	$747K	Buy	24,111 +3,135	+15%	+$107K	0.65%	50
2019 Q4	$779K	Buy	20,976 +5,233	+33%	+$186K	0.57%	55
2019 Q3	$537K	Buy	15,743 +1,718	+12%	+$62.5K	0.44%	63
2019 Q2	$577K	Sell	14,025 -715	-5%	-$28.4K	0.49%	58
2019 Q1	$594K	Sell	14,740 -211	-1%	-$8.45K	0.52%	54
2018 Q4	$619K	Buy	14,951 +177	+1%	+$7.35K	0.61%	47
2018 Q3	$618K	Sell	14,774 -614	-4%	-$23.6K	0.54%	53
2018 Q2	$530K	Sell	15,388 -5	-0%	-$171	0.48%	56
2018 Q1	$518K	Sell	15,393 -358	-2%	-$12.3K	0.49%	55
2017 Q4	$541K	Sell	15,751 -105	-0.7%	-$3.58K	0.51%	54
2017 Q3	$537K	Buy	15,856 +395	+3%	+$12.7K	0.51%	54
2017 Q2	$493K	Buy	15,461 +206	+1%	+$6.5K	0.48%	56
2017 Q1	$495K	Buy	15,255 +2,514	+20%	+$79.3K	0.51%	57
2016 Q4	$393K	Buy	+12,741	New	+$389K	0.37%	69

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Norway Savings Bank's PFE Position: Q2 2026 in Review

Norway Savings Bank reduced its Pfizer (PFE) stake by 4.3% in Q2 2026, selling an estimated $12.5K and leaving 10,701 shares worth $258K. The position accounts for 0.11% of the portfolio, ranked #98.

Norway Savings Bank first reported a position in PFE in Q4 2016 and has held it in 39 quarters since. The position peaked at $1.83M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Norway Savings Bank held 10,701 shares of Pfizer worth $258K as of Q2 2026.
Norway Savings Bank sold 476 Pfizer shares in Q2 2026, an estimated $12.5K.
Pfizer made up 0.11% of Norway Savings Bank's portfolio in Q2 2026, its #98 holding.
Norway Savings Bank first reported a position in Pfizer in Q4 2016 and has held it in 39 quarters since.
Norway Savings Bank's Pfizer position peaked at $1.83M in Q4 2021.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Norway Savings Bank's 13F filing for Q2 2026, filed 8 Jul 2026.